AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Advancements in Managing Bone Disease in Multiple Myeloma Patients
The chapter explores the latest developments in treating bone disease in multiple myeloma patients, focusing on BIS-Forsonate treatments like zoledronic acid and the alternative NOSOMAP for those with renal failure. Insights on the role of MMP13 metalloproteinase, PD1H interaction, and the reversibility of PD1 alterations post-treatment are discussed. Additionally, it covers the efficacy of esotuxumab, sequencing strategies for different therapies, outcomes of balamaf studies, and the safety profile of combination therapies.